Chemotherapy in NSCLC Patients With COPD Do Benefits Outweigh the Risks

Chemotherapy in NSCLC Patients With COPD: Do Benefits Outweigh the Risks?

09:41 EST 14 Dec 2018 | Cancer Networks

Researchers investigated whether first-line chemotherapy improved overall survival in NSCLC patients with severe to very severe COPD.

More From BioPortfolio on "Chemotherapy in NSCLC Patients With COPD: Do Benefits Outweigh the Risks?"